Acute Amanita muscaria Toxicity: A Literature Review and Two Case Reports in Elderly Spouses Following Home Preparation
Stanila Stoeva, Ivanesa Yarabanova, Maya Radeva–ilieva, Diana Ivanova, Snezha Zlateva, Petko Marinov
Toxins November 25, 2025 DOI: 10.3390/toxins17120570 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Sample size | 2 |
| Population | Elderly individuals with severe Amanita muscaria intoxication |
| Interventions | intensive supportive therapy atropine infusion continuous monitoring |
| Keywords | Disease Public health Clinical trial Poison control Sepsis Amanita Intensive care medicine |
| Citations | 4 |
| Key findings | Severe Amanita muscaria poisoning in elderly patients presents with rapid gastrointestinal symptoms, central nervous system depression, and cholinergic features, but full recovery is possible with intensive supportive therapy and atropine. |
Abstract
Amanita muscaria (L.) Lam., commonly known as fly agaric, remains an uncommon yet clinically important cause of acute mushroom intoxication. Although typically associated with mild to moderate neuropsychiatric disturbances, the mushroom’s toxic profile is highly variable and continues to attract scientific, toxicological, and public health interest. This work provides an integrative review of the biochemical composition, toxicodynamics, and clinical manifestations associated with A. muscaria exposure, with particular emphasis on the pharmacological actions of its principal constituents, ibotenic acid and muscimol. The review is complemented by two contemporaneous cases of severe intoxication in elderly individuals, illustrating the real-world clinical expression of the toxidrome and the challenges in diagnosis and management. Both cases presented with rapid-onset gastrointestinal symptoms, profound central nervous system depression, and cholinergic features, requiring intensive supportive therapy, atropine infusion, and continuous monitoring. Full recovery was achieved in both patients. These clinical observations contextualize the broader toxicological framework discussed in the review and underscore the need for increased clinical vigilance, improved public education, and strengthened diagnostic and therapeutic preparedness regarding psychoactive wild mushroom exposures.
Citations in the library
Cited by 4
- Ibotenic Acid and Muscimol in Amanita muscaria: Chemistry, Sources of Variability, Analytical Determination, and Toxicological Significance Molecules September 13, 2026
- Safety and Efficacy of Natural and Conventional Psychiatric Treatments: A Comparative Review of Mushroom-Derived Compounds and Medicinal Plants in the Management of Mental Disorders Molecules September 7, 2026
- Amanita muscaria in the evolving novel psychoactive substances landscape - toxicological risks and clinical implications: a narrative review Frontiers in Pharmacology May 26, 2026
- Amanitaphobia and the myth of suicide by fly agaric (Amanita muscaria) mushroom ingestion Journal of Psychedelic Studies August 13, 2026
Cites 16
- Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycological research February 1, 2003
- Toxicological Profiles of Poisonous, Edible, and Medicinal Mushrooms Mycobiology September 1, 2014
- Fly agaric (Amanita muscaria) poisoning, case report and review. Toxicon June 1, 2005
- Visual Hallucinations on Eye Closure Associated with Atropine Toxicity. A Neurological Analysis and Comparison with other Visual Hallucinations Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques February 1, 1991
- Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002-2016. Clinical Toxicology February 1, 2019
and 11 more in the library